Søk i kliniske studier for: 3-O-methyl-D-chiro-inositol
Totalt 2 resultater
-
University of ValenciaFullførtSunn | Type 2 diabetes | Nedsatt glukosetoleranseSpania
-
University of ValenciaFullførtSunn | InsulinfølsomhetSpania
Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.
Sponsorer og samarbeidspartnere
- Abidi Pharmaceuticals
- Calcivis Ltd
- Nakamura Memorial Hospital
- Beingmate Baby & Child Food Co Ltd .
- Centro OWLiver
- Aaron R. Mangold
- Fresenius Medical Care North America
- Haematology-Oncology
- Jingzhou Central Hospital
- American Osteopathic Association
- University of Illinois Sickle Cell Patient Council
- Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Cracow
- Jennifer Jones
- Norwegian Centre for Ageing and Health
- European Organisation for Research and Treatment of Cancer
- Comed B.V.
- Chilgok Kyungpook National University
- William Carson
- Freed Study Group
- Sahar Ahmed Abdalbary
- Vis full liste
Medisinsk tilstand
- Progesteronreseptornegativ (PR-negativ) brystkreft
- Dupuytren kontraktur
- Neoplasms, Neck
- Patent Foramen Ovale
- Røykere
- Smalt implantat
- Brokk, Paraesophageal
- COVID-19 postoperative komplikasjoner
- Kalorisk underskudd
- Glukosemetabolismeforstyrrelser (inkludert diabetes mellitus)
- Lukket fraktur av den proksimale humerus
- Serum Bank
- Pterygia
- Hyperkalemi som krever postoperativ dialyse
- Class II Caries in Premolars
- Hode- og nakkekarsinom, plateepitel
- Andre forhold som Risankizumab er en FDA-godkjent behandling for
- Stage IVA skjoldbruskkjertelen Anaplastisk karsinom AJCC v8
- Periprosedural myokardskade
- Barneforstyrrende atferdsforstyrrelser
- Vis full liste
Legemiddelintervensjoner
- Midazolam (del B)
- Seroquel (quetiapin)
- Taxotere
- Levofloxacin
- Interleukin-2 (Proleukin)
- Oksytocinbehandling
- Karboplatin
- Filgrastim
- OPC-249
- Docetaksel
- Iron-III Isomaltoside 1000
- Basal insulin
- Apatinib
- RBD1016
- CPX-POM - 120 mg/m^2
- Fase II ARRY-614 + nivolumab
- Behandling D: Doravirine 150 mg tablett (50 % legemiddelfylt granulat)
- BI 695501
- 20-hydroxyecdyson Oral
- Takrolimus 0,03% salve (Protopic)
- Vis full liste
CROs by country
- Contract Research Organizations in Belarus
- Contract Research Organizations in Colombia
- Contract Research Organizations in Estonia
- Contract Research Organizations in France
- Contract Research Organizations in Japan
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Romania
- Contract Research Organizations in Senegal
- Contract Research Organizations in Suriname
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Zambia
- CRO list by country